Yu P H, Davis B A, Boulton A A
Department of Psychiatry, University of Saskatchewan, Saskatoon, Canada.
Biochem Pharmacol. 1993 Aug 17;46(4):753-7. doi: 10.1016/0006-2952(93)90564-d.
A series of alkyl N-methyl-propargylamine derivatives has been discovered recently to be very potent selective irreversible monoamine oxidase B inhibitors (MAO-B). In the present study, we used a simple compound in this series, namely N-2-butyl-N-methylpropargylamine.HCl (2-BuMP), as the basic structure to investigate the effect of structural modification on the effectiveness and selectivity of the inhibition of MAO activities. When the N-methyl group was replaced by a hydrogen atom, an ethyl group or a propargyl group, MAO inhibitory activity was abolished. The modification of the propargyl group, e.g. to 3-butynyl, N-cyanomethyl or to allyl groups, also destroyed the inhibitory activity. The potency of the inhibitors was related to the carbon chain length of the alkyl group as well as to the substitution of the alpha or the terminal carbon atoms. Substitution of hydroxyl, carboxyl or carboethoxyl groups on the terminal carbon of the alkyl chain drastically reduced the inhibitory activity. More potent MAO inhibitory activity was observed for molecules with a single methyl group substitution on the alpha carbon in comparison with those substituted with two hydrogen or two methyl groups. Other branched alkyl N-methylpropargylamines, e.g. N-methyl-N-(3-pentyl)propargylamine, appeared to be slightly less selective in the inhibition of MAO-B activity. Some of these alkyl propargylamine MAO-B inhibitors, which do not possess the amphetamine-like moiety of L-deprenyl, may have significant neuropsychopharmacological implications.
最近发现一系列烷基N-甲基-炔丙胺衍生物是非常有效的选择性不可逆单胺氧化酶B抑制剂(MAO-B)。在本研究中,我们使用该系列中的一种简单化合物,即N-2-丁基-N-甲基炔丙胺·盐酸盐(2-BuMP)作为基本结构,来研究结构修饰对MAO活性抑制的有效性和选择性的影响。当N-甲基被氢原子、乙基或炔丙基取代时,MAO抑制活性消失。炔丙基的修饰,例如变为3-丁炔基、N-氰甲基或烯丙基,也会破坏抑制活性。抑制剂的效力与烷基的碳链长度以及α或末端碳原子的取代有关。在烷基链的末端碳原子上取代羟基、羧基或乙氧羰基会大大降低抑制活性。与那些被两个氢或两个甲基取代的分子相比,在α碳上有单个甲基取代的分子观察到更强的MAO抑制活性。其他支链烷基N-甲基炔丙胺,例如N-甲基-N-(3-戊基)炔丙胺,在抑制MAO-B活性方面似乎选择性稍低。这些不具有L-司来吉兰类似苯丙胺部分的烷基炔丙胺MAO-B抑制剂中的一些可能具有重要的神经精神药理学意义。